Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

49 results

Filters applied: . Clear all
Page 1
Consensus statement-graft treatment in cardiovascular bypass graft surgery.
Emmert MY, Bonatti J, Caliskan E, Gaudino M, Grabenwöger M, Grapow MT, Heinisch PP, Kieser-Prieur T, Kim KB, Kiss A, Mouriquhe F, Mach M, Margariti A, Pepper J, Perrault LP, Podesser BK, Puskas J, Taggart DP, Yadava OP, Winkler B. Emmert MY, et al. Among authors: perrault lp. Front Cardiovasc Med. 2024 Feb 27;11:1285685. doi: 10.3389/fcvm.2024.1285685. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 38476377 Free PMC article.
While there is little doubt about the benefits, the patency rates are constantly under debate. Despite its acknowledged limitations in terms of long-term patency due to intimal hyperplasia, the saphenous vein is still the most often used graft. ...
While there is little doubt about the benefits, the patency rates are constantly under debate. Despite its acknowledged limitations in terms …
Frailty and Bleeding in Older Adults Undergoing TAVR or SAVR: Insights From the FRAILTY-AVR Study.
Bendayan M, Messas N, Perrault LP, Asgar AW, Lauck S, Kim DH, Arora RC, Langlois Y, Piazza N, Martucci G, Lefèvre T, Noiseux N, Lamy A, Peterson MD, Labinaz M, Popma JJ, Webb JG, Afilalo J. Bendayan M, et al. Among authors: perrault lp. JACC Cardiovasc Interv. 2020 May 11;13(9):1058-1068. doi: 10.1016/j.jcin.2020.01.238. JACC Cardiovasc Interv. 2020. PMID: 32381184 Free article.
OBJECTIVES: The aim of this study was to examine the value of frailty to predict in-hospital major bleeding and determine its impact on mid-term mortality following transcatheter (TAVR) or surgical (SAVR) aortic valve replacement. ...CONCLUSIONS: Frailty is associated with …
OBJECTIVES: The aim of this study was to examine the value of frailty to predict in-hospital major bleeding and determine its impact on mid- …
Sequential multidetector computed tomography assessments after venous graft treatment solution in coronary artery bypass grafting.
Perrault LP, Carrier M, Voisine P, Olsen PS, Noiseux N, Jeanmart H, Cardemartiri F, Veerasingam D, Brown C, Guertin MC, Satishchandran V, Goeken T, Emmert MY. Perrault LP, et al. J Thorac Cardiovasc Surg. 2021 Jan;161(1):96-106.e2. doi: 10.1016/j.jtcvs.2019.10.115. Epub 2019 Nov 9. J Thorac Cardiovasc Surg. 2021. PMID: 31866081 Free article.
CONCLUSIONS: DuraGraft demonstrated a favorable effect on wall thickness at 12 months, particularly in the proximal segment. Longer-term follow-up in larger studies is needed to evaluate the effect on clinical outcomes....
CONCLUSIONS: DuraGraft demonstrated a favorable effect on wall thickness at 12 months, particularly in the proximal segment. Longer-term …
A novel endothelial damage inhibitor for the treatment of vascular conduits in coronary artery bypass grafting: protocol and rationale for the European, multicentre, prospective, observational DuraGraft registry.
Caliskan E, Sandner S, Misfeld M, Aramendi J, Salzberg SP, Choi YH, Satishchandran V, Iyer G, Perrault LP, Böning A, Emmert MY. Caliskan E, et al. Among authors: perrault lp. J Cardiothorac Surg. 2019 Oct 15;14(1):174. doi: 10.1186/s13019-019-1010-z. J Cardiothorac Surg. 2019. PMID: 31615560 Free PMC article.
BACKGROUND: Vein graft disease (VGD) impairs graft patency rates and long-term outcomes after coronary artery bypass grafting (CABG). DuraGraft is a novel endothelial-damage inhibitor developed to efficiently protect the structural and functional integrity of the vascular …
BACKGROUND: Vein graft disease (VGD) impairs graft patency rates and long-term outcomes after coronary artery bypass grafting (CABG). …
Saphenous vein grafts in contemporary coronary artery bypass graft surgery.
Caliskan E, de Souza DR, Böning A, Liakopoulos OJ, Choi YH, Pepper J, Gibson CM, Perrault LP, Wolf RK, Kim KB, Emmert MY. Caliskan E, et al. Among authors: perrault lp. Nat Rev Cardiol. 2020 Mar;17(3):155-169. doi: 10.1038/s41569-019-0249-3. Epub 2019 Aug 27. Nat Rev Cardiol. 2020. PMID: 31455868 Review.
Vein graft disease (VGD) and failure result from complex pathophysiological processes that can lead to complete occlusion of the graft, affecting long-term clinical outcomes. Optimal harvesting techniques, intraoperative preservation strategies and intraoperative patency c …
Vein graft disease (VGD) and failure result from complex pathophysiological processes that can lead to complete occlusion of the graft, affe …
Association of Depression With Mortality in Older Adults Undergoing Transcatheter or Surgical Aortic Valve Replacement.
Drudi LM, Ades M, Turkdogan S, Huynh C, Lauck S, Webb JG, Piazza N, Martucci G, Langlois Y, Perrault LP, Asgar AW, Labinaz M, Lamy A, Noiseux N, Peterson MD, Arora RC, Lindman BR, Bendayan M, Mancini R, Trnkus A, Kim DH, Popma JJ, Afilalo J. Drudi LM, et al. Among authors: perrault lp. JAMA Cardiol. 2018 Mar 1;3(3):191-197. doi: 10.1001/jamacardio.2017.5064. JAMA Cardiol. 2018. PMID: 29344620 Free PMC article.
CONCLUSIONS AND RELEVANCE: One in 3 older adults undergoing TAVR or SAVR had depressive symptoms at baseline and a higher risk of short-term and midterm mortality. Patients with persistent depressive symptoms at follow-up had the highest risk of mortality....
CONCLUSIONS AND RELEVANCE: One in 3 older adults undergoing TAVR or SAVR had depressive symptoms at baseline and a higher risk of short-t …
Changes in patient characteristics following cardiac transplantation: the Montreal Heart Institute experience.
Vistarini N, Nguyen A, White M, Racine N, Perrault LP, Ducharme A, Bouchard D, Demers P, Pellerin M, Lamarche Y, El-Hamamsy I, Giraldeau G, Pelletier G, Carrier M. Vistarini N, et al. Among authors: perrault lp. Can J Surg. 2017 Sep;60(5):305-310. doi: 10.1503/cjs.005716. Can J Surg. 2017. PMID: 28805187 Free PMC article.
The aim of this study was to review the heart transplant experience focusing on very long-term survival ( 20 years) and to compare the initial results with the current era. ...Patients in group 3 (n = 54) were older (52 12 v. 38 11 yr, p = 0.001), sicker (rate of hospital …
The aim of this study was to review the heart transplant experience focusing on very long-term survival ( 20 years) and to compare th …
Pericardiectomy for Constrictive Pericarditis: 20 Years of Experience at the Montreal Heart Institute.
Vistarini N, Chen C, Mazine A, Bouchard D, Hebert Y, Carrier M, Cartier R, Demers P, Pellerin M, Perrault LP. Vistarini N, et al. Among authors: perrault lp. Ann Thorac Surg. 2015 Jul;100(1):107-13. doi: 10.1016/j.athoracsur.2015.02.054. Epub 2015 May 13. Ann Thorac Surg. 2015. PMID: 25979240
BACKGROUND: The aim of this study was to evaluate our single-center experience with pericardiectomy for constrictive pericarditis. The main objectives of our analysis were long-term survival, clinical outcome, and identification of risk factors. ...In cases of isolated per …
BACKGROUND: The aim of this study was to evaluate our single-center experience with pericardiectomy for constrictive pericarditis. The main …
Surgical treatment of moderate ischemic mitral regurgitation.
Smith PK, Puskas JD, Ascheim DD, Voisine P, Gelijns AC, Moskowitz AJ, Hung JW, Parides MK, Ailawadi G, Perrault LP, Acker MA, Argenziano M, Thourani V, Gammie JS, Miller MA, Pagé P, Overbey JR, Bagiella E, Dagenais F, Blackstone EH, Kron IL, Goldstein DJ, Rose EA, Moquete EG, Jeffries N, Gardner TJ, O'Gara PT, Alexander JH, Michler RE; Cardiothoracic Surgical Trials Network Investigators. Smith PK, et al. Among authors: perrault lp. N Engl J Med. 2014 Dec 4;371(23):2178-88. doi: 10.1056/NEJMoa1410490. Epub 2014 Nov 18. N Engl J Med. 2014. PMID: 25405390 Free PMC article. Clinical Trial.
Thus, at 1 year, this trial did not show a clinically meaningful advantage of adding mitral-valve repair to CABG. Longer-term follow-up may determine whether the lower prevalence of mitral regurgitation translates into a net clinical benefit. ...
Thus, at 1 year, this trial did not show a clinically meaningful advantage of adding mitral-valve repair to CABG. Longer-term follow- …
Surgical treatments for patients with terminal heart failure: mechanical support compared with transplantation.
Carrier M, Perrault LP. Carrier M, et al. Among authors: perrault lp. Can J Cardiol. 2014 Dec;30(12 Suppl):S455-8. doi: 10.1016/j.cjca.2014.06.024. Epub 2014 Jul 3. Can J Cardiol. 2014. PMID: 25284807 Review.
Should we recommend continuous flow pump implantations in patients with various comorbidities, and offer transplantation to a selected group of patients who will reach the long-term benefit of the procedure?...
Should we recommend continuous flow pump implantations in patients with various comorbidities, and offer transplantation to a selected group …
49 results